Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virus shedding after bOPV at different dosing intervals in children
ChiCTR2500103863Phase 4Not yet recruiting
- Sponsor
- Chinese Center for Disease Control and Prevention
- Start
- Jun 2025
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of bivalent oral poliovirus vaccine in poliomyelitis (5 arms), sponsored by Chinese Center for Disease Control and Prevention. Primary endpoints: Virus isolation and intratypic differentiation and Secretory IgA. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
bivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on ChiCTR2500103863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103863.